Skip to main content

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 7, Number 4, April 2006

Articles

Favourites:
ADD

Resveratrol as a Chemopreventive Agent: A Promising Molecule for Fighting Cancer
pp. 423-442(20)
Authors: Delmas, Dominique; Lancon, Allan; Colin, Didier; Jannin, Brigitte; Latruffe, Norbert

Favourites:
ADD
Favourites:
ADD

Fungal ATP-Binding Cassette (ABC) Transporters in Drug Resistance & Detoxification
pp. 471-481(11)
Authors: Sipos, Gyorgy; Kuchler, Karl

Favourites:
ADD

Host-Pathogen Interactions and the Pathological Consequences of Acute Systemic Candida albicans Infections in Mice
pp. 483-494(12)
Authors: Rozell, Bjorn; Ljungdahl, Per O.; Martínez, Paula

Favourites:
ADD
Favourites:
ADD

Getting in Touch with Candida albicans: The Cell Wall of a Fungal Pathogen
pp. 505-512(8)
Authors: Sohn, Kai; Schwenk, Jochen; Urban, Constantin; Lechner, Johannes; Schweikert, Michael; Rupp, Steffen

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more